Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1884 1
1890 1
1896 1
1909 1
1911 1
1920 1
1929 1
1939 1
1945 4
1946 3
1947 7
1948 4
1949 8
1950 14
1951 10
1952 21
1953 14
1954 5
1955 14
1956 21
1957 10
1958 10
1959 13
1960 15
1961 19
1962 16
1963 64
1964 60
1965 36
1966 57
1967 64
1968 84
1969 78
1970 105
1971 96
1972 124
1973 156
1974 108
1975 124
1976 135
1977 119
1978 117
1979 129
1980 143
1981 181
1982 185
1983 175
1984 202
1985 232
1986 182
1987 238
1988 236
1989 307
1990 311
1991 284
1992 283
1993 291
1994 327
1995 303
1996 324
1997 316
1998 321
1999 331
2000 336
2001 346
2002 364
2003 390
2004 379
2005 430
2006 394
2007 428
2008 459
2009 411
2010 483
2011 474
2012 506
2013 550
2014 553
2015 616
2016 570
2017 665
2018 655
2019 708
2020 744
2021 894
2022 814
2023 91
Text availability
Article attribute
Article type
Publication date

Search Results

18,027 results
Results by year
Filters applied: . Clear all
Page 1
Primary biliary cholangitis: pathogenesis and therapeutic opportunities.
Gulamhusein AF, Hirschfield GM. Gulamhusein AF, et al. Nat Rev Gastroenterol Hepatol. 2020 Feb;17(2):93-110. doi: 10.1038/s41575-019-0226-7. Epub 2019 Dec 9. Nat Rev Gastroenterol Hepatol. 2020. PMID: 31819247 Review.
Primary biliary cholangitis is a chronic, seropositive and female-predominant inflammatory and cholestatic liver disease, which has a variable rate of progression towards biliary cirrhosis. ...A current focus of research on nuclear recept
Primary biliary cholangitis is a chronic, seropositive and female-predominant inflammatory and cholestatic liver
Primary biliary cholangitis: treatment.
Cazzagon N, Floreani A. Cazzagon N, et al. Curr Opin Gastroenterol. 2021 Mar 1;37(2):99-104. doi: 10.1097/MOG.0000000000000708. Curr Opin Gastroenterol. 2021. PMID: 33492001 Review.
PURPOSE OF REVIEW: To discuss the most recent data regarding treatment of patients with primary biliary cholangitis (PBC) with inadequate response to ursodeoxycholic acid (UDCA). ...
PURPOSE OF REVIEW: To discuss the most recent data regarding treatment of patients with primary biliary cholangitis (PB …
Primary biliary cholangitis.
Parés A. Parés A. Med Clin (Barc). 2018 Sep 21;151(6):242-249. doi: 10.1016/j.medcli.2017.12.021. Epub 2018 Mar 9. Med Clin (Barc). 2018. PMID: 29526309 Review. English, Spanish.
Primary cholangitis (cirrhosis) is a chronic cholestatic disease with an unquestionable female predominance. ...The positivity of these antibodies and a biochemical cholestasis are sufficient for diagnosis, without the need for liver biopsy. Ursodeoxyc
Primary cholangitis (cirrhosis) is a chronic cholestatic disease with an unquestionable female predominance. ...The pos
Primary Biliary Cholangitis and Autoimmune Hepatitis.
Gonzalez RS, Washington K. Gonzalez RS, et al. Surg Pathol Clin. 2018 Jun;11(2):329-349. doi: 10.1016/j.path.2018.02.010. Surg Pathol Clin. 2018. PMID: 29751878 Review.
Primary biliary cholangitis and autoimmune hepatitis are common autoimmune diseases of the liver. ...First-line therapy is immunosuppression for autoimmune hepatitis and ursodeoxycholic acid for primary biliary cholangitis. Both di
Primary biliary cholangitis and autoimmune hepatitis are common autoimmune diseases of the liver. ...First-line
Extrahepatic Manifestations of Primary Biliary Cholangitis.
Chalifoux SL, Konyn PG, Choi G, Saab S. Chalifoux SL, et al. Gut Liver. 2017 Nov 15;11(6):771-780. doi: 10.5009/gnl16365. Gut Liver. 2017. PMID: 28292174 Free PMC article. Review.
Primary biliary cholangitis (PBC) is an autoimmune liver disease characterized by progressive destruction of the intrahepatic bile ducts, leading to cholestasis. ...
Primary biliary cholangitis (PBC) is an autoimmune liver disease characterized by progressive destruction of the
Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis.
Sarcognato S, Sacchi D, Grillo F, Cazzagon N, Fabris L, Cadamuro M, Cataldo I, Covelli C, Mangia A, Guido M. Sarcognato S, et al. Pathologica. 2021 Jun;113(3):170-184. doi: 10.32074/1591-951X-245. Pathologica. 2021. PMID: 34294935 Free PMC article. Review.
Primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) are the main autoimmune cholestatic liver diseases. Both may evolve into secondary biliary cirrhosis and its complications. Therapeutic options are l
Primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) are the main autoimmune choles
Diagnosis and Management of Primary Biliary Cholangitis.
Younossi ZM, Bernstein D, Shiffman ML, Kwo P, Kim WR, Kowdley KV, Jacobson IM. Younossi ZM, et al. Am J Gastroenterol. 2019 Jan;114(1):48-63. doi: 10.1038/s41395-018-0390-3. Am J Gastroenterol. 2019. PMID: 30429590 Review.
Primary biliary cholangitis (PBC) is a chronic, cholestatic, autoimmune disease with a variable progressive course. PBC can cause debilitating symptoms including fatigue and pruritus and, if left untreated, is associated with a high risk of cirrhosis a
Primary biliary cholangitis (PBC) is a chronic, cholestatic, autoimmune disease with a variable progressive course. PBC
Current and potential treatments for primary biliary cholangitis.
Shah RA, Kowdley KV. Shah RA, et al. Lancet Gastroenterol Hepatol. 2020 Mar;5(3):306-315. doi: 10.1016/S2468-1253(19)30343-7. Epub 2019 Dec 2. Lancet Gastroenterol Hepatol. 2020. PMID: 31806572 Review.
Up to 40% of patients with primary biliary cholangitis have an incomplete response to first-line treatment with ursodeoxycholic acid. ...Bezafibrate, a pan-peroxisome proliferator-activated receptor agonist, has been shown to ameliorate deranged bile acid hom …
Up to 40% of patients with primary biliary cholangitis have an incomplete response to first-line treatment with ursodeo …
The Pathogenesis of Primary Biliary Cholangitis: A Comprehensive Review.
Lleo A, Leung PSC, Hirschfield GM, Gershwin EM. Lleo A, et al. Semin Liver Dis. 2020 Feb;40(1):34-48. doi: 10.1055/s-0039-1697617. Epub 2019 Sep 19. Semin Liver Dis. 2020. PMID: 31537031 Review.
Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by autoimmune destruction of small to medium size intrahepatic bile ducts. The etiology of PBC remains unknown and pathogenesis features immune-mediated biliary
Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by autoimmune destruction
Primary Biliary Cholangitis: Its Pathological Characteristics and Immunopathological Mechanisms.
Tsuneyama K, Baba H, Morimoto Y, Tsunematsu T, Ogawa H. Tsuneyama K, et al. J Med Invest. 2017;64(1.2):7-13. doi: 10.2152/jmi.64.7. J Med Invest. 2017. PMID: 28373632 Free article. Review.
Primary biliary cholangitis (PBC), formerly known as primary biliary cirrhosis, is an organ-specific autoimmune disease that predominantly affects middle-aged women and is characterized by the chronic progressive destruction of small intr
Primary biliary cholangitis (PBC), formerly known as primary biliary cirrhosis, is an organ-specif
18,027 results
You have reached the last available page of results. Please see the User Guide for more information.